About Ashley Franklin

Ashley Franklin is a strategist, consultant, and operator dedicated to helping mission driven founders and organizations scale their impact, with deep roots in healthcare. At Boehringer Ingelheim, she serves as Manager of Strategy and Internal Consulting, leading initiatives that expand healthcare access and advance innovation. Ashley previously served as an Impact Investment Associate at Angel City Advisors, supporting the Echoing Green Signal Fund, a catalytic capital vehicle for global social entrepreneurs.

She went on to join Novo Nordisk's Strategic Partnerships team, where she sourced and evaluated partnerships with early-stage startups and venture backed companies, built investment cases that secured $20 million in approved capital, and supported strategic telehealth partnerships to expand access to cardiometabolic care.

Earlier in her career, Ashley was a Venture Strategist at Johnson & Johnson, where she helped design Johnson & Johnson Impact Ventures, a $50 million impact seed fund under the Johnson & Johnson Foundation. She led global research with fund managers and entrepreneurs to redefine founder support strategy and shape the fund's early-stage investment approach.

Ashley holds a BS from Eastern Connecticut State University, an MBA from Temple University, and a Venture Capital Investing Certificate from VC University at UC Berkeley School of Law. She is currently pursuing a Master of Health Care Innovation at the University of Pennsylvania. Ashley lives in New York City. Outside of work, she loves spending time with family, traveling the world, and reading a good book.